M&A Deal Summary

Kindeva Drug Delivery Acquires Meridian Medical Technologies

On November 14, 2022, Kindeva Drug Delivery acquired life science company Meridian Medical Technologies from Altaris

Acquisition Highlights
  • This is Kindeva Drug Delivery’s 1st transaction in the Life Science sector.
  • This is Kindeva Drug Delivery’s 1st transaction in the United States.
  • This is Kindeva Drug Delivery’s 1st transaction in Missouri.

M&A Deal Summary

Date 2022-11-14
Target Meridian Medical Technologies
Sector Life Science
Buyer(s) Kindeva Drug Delivery
Sellers(s) Altaris
Deal Type Merger

Target

Meridian Medical Technologies

St. Louis, Missouri, United States
Meridian Medical Technologies designs, develops, manufactures and supplies on-the-scene emergency response treatments and health security solutions with a focus on complex drug-device combination products. Meridian Medical Technologies is based in St. Louis, Missouri.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Kindeva Drug Delivery

Woodbury, Minnesota, United States

Category Company
Sector Life Science
DESCRIPTION

Kindeva Drug Delivery engages in drug delivery that partners with pharmaceutical and biotech companies to develop and manufacture pharmaceutical products using its unique inhalation, transdermal, microneedle, or conventional drug delivery technologies. Kindeva Drug Delivery is based in Woodbury, Minnesota.


DEAL STATS #
Overall 1 of 2
Sector: Life Science M&A 1 of 2
Type: Merger M&A Deals 1 of 1
State: Missouri M&A 1 of 1
Country: United States M&A 1 of 2
Year: 2022 M&A 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-01-18 Summit Biosciences

Lexington, Kentucky, United States

Summit Biosciences is an intranasal drug-delivery contract development and manufacturing organization. Summit Biosciences was founded in 2009 and is based in Lexington, Kentucky.

Buy -

Seller(S) 1

SELLER

Altaris

New York City, New York, United States

Investor Investor Investor


Category Private Equity Firm
Founded 2003
PE ASSETS 10.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Altaris is a specialist private equity firm that targets investments in the healthcare industry. Altaris focuses its investment activity across the healthcare sector, including pharmaceuticals, medical devices, healthcare services and healthcare IT. Altaris will consider both control and non-control investment situations requiring $15 to $50 million of equity capital. Prospective investment situations include corporate carve-outs, leveraged buyouts, and growth equity/recapitalization investments. Altaris was formed in 2004 and is based in New York, New York.


DEAL STATS #
Overall 26 of 28
Sector: Life Science M&A 3 of 3
Type: Merger M&A Deals 2 of 2
State: Missouri M&A 1 of 1
Country: United States M&A 24 of 26
Year: 2022 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-02-28 IntriCon

St. Paul, Minnesota, United States

IntriCon is a manufacturer and distributor of miniature and micro-miniature body-worn devices for the health care industry. IntriCon was founded in 1930 and is based in St. Paul, Minnesota.

Buy $241M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-12-16 Trean Insurance

Wayzata, Minnesota, United States

Trean Insurance provides products and services to the specialty insurance market. Trean underwrites specialty casualty insurance products both through its program partners and its own managing general agencies. Trean also provides its program partners with a variety of services including issuing carrier services, claims administration, and reinsurance brokerage. Trean Insurance was formed in 1996 and is based in Wayzata, Minnesota.

Buy $316M